Prevalence of hair loss in Egyptian people after covid -19 vaccination.
Ammar, A., Shahin, I., Mohamed, A. (2644). Prevalence of hair loss in Egyptian people after covid -19 vaccination.. EKB Journal Management System, 2023(1), -. doi: 10.58675/2682-339X.1928
Amr Mohammad Ammar; Ibrahim Mohamed Ibrahim Shahin; Abbas Nabil Mohamed. "Prevalence of hair loss in Egyptian people after covid -19 vaccination.". EKB Journal Management System, 2023, 1, 2644, -. doi: 10.58675/2682-339X.1928
Ammar, A., Shahin, I., Mohamed, A. (2644). 'Prevalence of hair loss in Egyptian people after covid -19 vaccination.', EKB Journal Management System, 2023(1), pp. -. doi: 10.58675/2682-339X.1928
Ammar, A., Shahin, I., Mohamed, A. Prevalence of hair loss in Egyptian people after covid -19 vaccination.. EKB Journal Management System, 2644; 2023(1): -. doi: 10.58675/2682-339X.1928

Prevalence of hair loss in Egyptian people after covid -19 vaccination.

Al-Azhar International Medical Journal
Volume 2023, Issue 1, January 2023  XML
DOI: 10.58675/2682-339X.1928
View on SCiNiTO View on SCiNiTO
Authors
Amr Mohammad Ammar1; Ibrahim Mohamed Ibrahim Shahin1; Abbas Nabil Mohamed2
1Dermatology, Venereology and Andrology department, Al Hussein Hospital- Al-Azhar University, Egypt.
2Dermatology, Venereology and Andrology department, Al Hussein Hospital- Al-Azhar University, Egypt
Abstract
Background: Coronavirus disease 2019 currently named SARS-CoV-2 is a contagious disease caused by a coronavirus the illness that the World Health Organization considers to be a pandemic worldwide. In Egypt, over 288 thousand COVID-19 confirmed cases with about 16.676 thousand total deaths until Aug 2021; COVID-19 vaccination can cause several adverse events including hair loss, however there are incompatible data are present on the possible relationship among COVID-19 vaccines and hair loss. Aim and objectives: Our aim is to study and evaluate the prevalence of hair loss confirmed by dermoscope in Egyptian people after covid-19 vaccination. Patient and methods: This prospective study included two thousand participants aged 20-60 years old and received COVID-19 vaccination during the period of January 2022 to July 2022 from the outpatient clinics of dermatology and venereology departments, Al-Azhar University Hospitals. Result: The findings in this study reported that among the studied cases the predominant vaccination drug was AstraZeneca vaccine with 524 (26.2%) cases ,however (1.6%) received Johnson & Johnson vaccine, (.6%) received Moderna vaccine, (3.4%) received Pfizer vaccine, (23.8%) received Sinopharm vaccine, (20.8%) received Sinovac vaccine, (19.0%) received Sputnik vaccine and (4.5%) received Sputnik light vaccine. 478 cases (23.9%) complained of hair loss and 1522 cases (76.1%) didn’t complain of hair loss after COVID-19 vaccination. Conclusion: Covid-19 vaccination should be considered as a potential cause of hair loss.
Statistics
Article View: 16